MAPT and Alzheimer disease: O-GlcNAcylation modulates several pathways involved in AD pathogenesis, such as APP processing (Jacobsen and Iverfeldt, 2011), tau phosphorylation (Liu et al., 2004, 2009), synaptic integrity (Tallent et al., 2009), and insulin signaling (Yang et al., 2008).